• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

rhicks@unimelb.edu.au

Credentials


Position
Honorary Clinical Professor
Department of Medicine
Education
Bachelors Degree
Monash University
Bachelors Degree
Monash University
ORCID

0000-0002-0758-0824

Prof Rodney Hicks

Honorary Clinical Professor
Department of Medicine

1007 Scholarly works
27 Projects

HIGHLIGHTS

  • 2020

    Research grants (ARC, NHMRC, MRFF)

    Evaluation of Fibroblastic Activation Protein Inhibitors (FAPI) as a Novel Radiopharmaceutical Targeting Cancer-Associated Fibroblasts for the Diagnosis and Treatment of Patients With Cancer of Unknown Primary: The FAPI-CUP Trial
  • 2018

    Journal article

    Cold kit for prostate-Specific membrane antigen (PSMA) PET imaging: Phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
    DOI: 10.2967/jnumed.117.199554
  • 2018

    Journal article

    Ibrutinib plus venetoclax for the treatment of mantle-cell lymphoma
    DOI: 10.1056/NEJMoa1715519
  • 2017

    Conference Proceedings

    Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA
    DOI: 10.1093/annonc/mdx370.002
  • 2017

    Research Grant

    Acrf Tumour Heterogeneity Program
  • 2017

    Conference Proceedings

    Cold Kit PSMA Imaging: First In-Man Study of 68Ga-THP-PSMA PET/CT in Patients with Prostate Cancer
  • 2017

    Research grants (other domestic)

    Novel Approaches for Overcoming Resistance to Therapies for Advanced Melanoma
Rodney Hicks

Latest Honours,
Awards and Fellowships


2004
Fellow of the Royal Australasian College of Physicians (FRACP)

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    Fully Automated Segmentation of [18F]FDG and [68Ga]/[18F]PSMA PET/CT Images via Data-Centric Deep Learning.
    DOI: 10.2967/jnumed.126.272852
  • 2026

    Journal article

    Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes.
    DOI: 10.1158/1078-0432.CCR-25-4720
  • 2026

    Journal article

    Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.
    DOI: 10.2967/jnumed.126.273266
  • 2026

    Journal article

    Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).
    DOI: 10.1016/S1470-2045(26)00145-2
  • 2026

    Journal article

    Whole genome and exome sequencing of pancreatic neuroendocrine tumour to investigate PRRT response
    DOI: 10.1530/ERC-26-0207
  • 2026

    Journal article

    Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: AJR Expert Panel Narrative Review.
    DOI: 10.2214/AJR.26.35081
  • 2026

    Journal article

    My Life as a "Theranostician": A commentary on the evolution of theranostics.
    DOI: 10.1038/s44303-026-00171-w
  • 2026

    Journal article

    FAPI-CUP: A prospective cohort study of patients with cancer of unknown primary (CUP) to evaluate a novel radiotracer, fibroblast activated protein (FAPI), targeting cancer-associated fibroblasts for primary site detection.
    DOI: 10.1200/jco.2026.44.16_suppl.3072

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224